Filing Details
- Accession Number:
- 0001225208-17-010054
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-18 16:25:13
- Reporting Period:
- 2017-05-17
- Filing Date:
- 2017-05-18
- Accepted Time:
- 2017-05-18 16:25:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1566080 | J. Kevin Ballinger | 300 Boston Scientific Way Marlborough MA 01752-1234 | Evp & Pres, Interven Cardio | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-05-03 | 400 | $0.00 | 86,230 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2017-05-17 | 12,776 | $26.09 | 73,454 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-05-17 | 16,088 | $26.18 | 57,366 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- Represents the weighted average sale price. These shares were sold in multiple transactions at $26.09 and $26.10. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.17 to $26.181, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
